Cardiovascular health and the modifiable burden of incident myocardial infarction: The Tromsø Study

BMC Public Health

Volumn 15, Issue 1, 2015, Pages

  Wilsgaard, Tom ^a,b   Loehr, Laura R ^b   Mathiesen, Ellisiv B ^a   Løchen, Maja Lisa ^a   Bønaa, Kaare H ^a,c   Njølstad, Inger ^a   Heiss, Gerardo ^b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b IL   (United States)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Cohort studies; Coronary heart disease; Lifestyle; Longitudinal studies; Prevention

Indexed keywords

ADULT; AGED; COST OF ILLNESS; FEMALE; HEALTH STATUS; HEALTH SURVEY; HUMAN; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NORWAY; PROCEDURES; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; COST OF ILLNESS; FEMALE; HEALTH STATUS; HEALTH SURVEYS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NORWAY; RISK FACTORS;

EID: 84928716878     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/s12889-015-1573-0     Document Type: Article

References (32)

1. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119:e21-181.
2. Kesteloot H, Sans S, Kromhout D. Dynamics of cardiovascular and all-cause mortality in Western and Eastern Europe between 1970 and 2000. Eur Heart J. 2006;27:107-13.
3. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095-128.
4. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2197-223.
5. Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation. 2010;121:586-613.
6. Folsom AR, Yatsuya H, Nettleton JA, Lutsey PL, Cushman M, Rosamond WD, et al. Community prevalence of ideal cardiovascular health, by the American Heart Association definition, and relationship with cardiovascular disease incidence. J Am Coll Cardiol. 2011;57:1690-6.
7. He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C, Whelton PK. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med. 2001;161:996-1002.
8. Kenchaiah S, Narula J, Vasan RS. Risk factors for heart failure. Med Clin North Am. 2004;88:1145-72.
9. Benichou J. A review of adjusted estimators of attributable risk. Stat Methods Med Res. 2001;10:195-216.
10. Loehr LR, Rosamond WD, Poole C, McNeill AM, Chang PP, Deswal A, et al. The potentially modifiable burden of incident heart failure due to obesity: the atherosclerosis risk in communities study. Am J Epidemiol. 2010;172:781-9.
11. Morgenstern H, Bursic ES. A method for using epidemiologic data to estimate the potential impact of an intervention on the health status of a target population. J Community Health. 1982;7:292-309.
12. Rose G. Sick individuals and sick populations. Int J Epidemiol. 1985;14:32-8.
13. Jacobsen BK, Eggen AE, Mathiesen EB, Wilsgaard T, Njølstad I. Cohort profile: The Tromsø Study. Int J Epidemiol. 2011;doi:10.1093/ije/dyr049.
14. Welcome to research data from the Tromsø Study. [ http://tromsoundersokelsen.uit.no/tromso/ ].
15. Walter SD. Prevention for multifactorial diseases. Am J Epidemiol. 1980;112:409-16.
16. Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, et al. American Heart Association Statistics C, Stroke Statistics S: Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006;113:e85-151.
17. Wisløff T, Selmer RM, Halvorsen S, Kristiansen IS. Norwegian Cardiovascular disease model (NorCaD). Report Nr 23-2008. Norwegian Knowledge Centre for the Health Services: Oslo; 2008.
18. Mannsverk J, Wilsgaard T, Njølstad I, Hopstock LA, Løchen ML, Mathiesen EB, et al. Age and gender differences in incidence and case fatality trends for myocardial infarction: a 30-year follow-up. The Tromsø Study. Eur J Prev Cardiol. 2012;19:927-34.
19. Eggen AE, Mathiesen EB, Njølstad I, Jacobsen BK, Wilsgaard T. Trends in cardiovascular risk factors across levels of education in a general population: Is the educational gap increasing? The Tromsø Study 1994-2008. J Epidemiol Community Health. 2014;68:712-9.
20. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA. 2012;307:491-7.
21. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:e442.
22. Popkin BM, Slining MM. New dynamics in global obesity facing low- and middle-income countries. Obes Rev. 2013;14 Suppl 2:11-20.
23. Zhai FY, Du SF, Wang ZH, Zhang JG, Du WW, Popkin BM. Dynamics of the Chinese diet and the role of urbanicity, 1991-2011. Obes Rev. 2014;15 Suppl 1:16-26.
24. Erlinger TP, Vollmer WM, Svetkey LP, Appel LJ. The potential impact of nonpharmacologic population-wide blood pressure reduction on coronary heart disease events: pronounced benefits in African-Americans and hypertensives. Prev Med. 2003;37:327-33.
25. Emberson J, Whincup P, Morris R, Walker M, Ebrahim S. Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease. Eur Heart J. 2004;25:484-91.
26. Prospective Studies C, Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373:1083-96.
27. Vasan RS, Sullivan LM, Wilson PW, Sempos CT, Sundstrom J, Kannel WB, et al. Relative importance of borderline and elevated levels of coronary heart disease risk factors. Ann Intern Med. 2005;142:393-402.
28. Lloyd-Jones DM, Leip EP, Larson MG, D'Agostino RB, Beiser A, Wilson PW, et al. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation. 2006;113:791-8.
29. Stamler J, Stamler R, Neaton JD, Wentworth D, Daviglus ML, Garside D, et al. Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. JAMA. 1999;282:2012-8.
30. Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med. 2000;343:16-22.
31. Hozawa A, Folsom AR, Sharrett AR, Chambless LE. Absolute and attributable risks of cardiovascular disease incidence in relation to optimal and borderline risk factors: comparison of African American with white subjects-Atherosclerosis Risk in Communities Study. Arch Intern Med. 2007;167:573-9.
32. Huffman MD, Capewell S, Ning H, Shay CM, Ford ES, Lloyd-Jones DM. Cardiovascular health behavior and health factor changes (1988-2008) and projections to 2020: results from the National Health and Nutrition Examination Surveys. Circulation. 2012;125:2595-602.